News
EyeGate licenses orphan eye disease patents to Avedro
Fri, 10/26/2012 - 12:00am
EyeGate Pharmaceuticals Inc. is licensing its patents relating to a treatment for an orphan eye disease called keratoconus to its Waltham neighbor Avedro Inc. for an undisclosed sum.
